Please login to the form below

Not currently logged in
Email:
Password:

Cancer Insights

This page shows the latest Cancer Insights news and features for those working in and with pharma, biotech and healthcare.

FDA and Flatiron extend real world evidence collaboration

FDA and Flatiron extend real world evidence collaboration

The FDA's Richard Pazdur. In the first phase of the partnership, Flatiron provided the FDA with de-identified datasets to provide insights on cancer patients with advanced non-small cell ... lung cancer being treated with immunotherapy (see  here and 

Latest news

  • Pharma shares data on cancer projects Pharma shares data on cancer projects

    Cancer Centre in the US - designed to collect cancer research data in a single location. ... Howard Scher, chief of the genitourinary oncology service at Memorial Sloan Kettering Cancer Centre, said the PDS: "will enable the research community to bring

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Oncology drugs under AMNOG: part two Oncology drugs under AMNOG: part two

    Patient-relevant outcomes and the 'added benefit' of cancer drugs. We conclude our look at AMNOG and cancer drugs with some insights from the benefit assessment process and focus on the ... Analysis of decisions on cancer drugs over the past three years

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...